“Dapagliflozin and Sitagliptin Combination Therapy: An Overview of Clinical Utility in Type 2 Diabetes Mellitus with Multiple Cardiovascular Risk Factors” (2023) Cardiology and Cardiovascular Medicine, 7(2), pp. 141–144. Available at: https://fortunejournals.org/ojs/index.php/ccm/article/view/16403 (Accessed: 17 September 2026).